Rare disease patients caught in Trump crackdown on foreign grant awards

NIH rejects research over paperwork glitches: "It's so devastating for this community."

August 6, 2025 Check out STAT+

Sponsored By

Snag this deal: Save 50% off a STAT+ annual subscription and get unlimited access to our award-winning stories, premium data tools, event discounts, and more.

Kayana Szymczak for STAT STAT+ | Rare disease patients caught in Trump crackdown on foreign grant awards In studies reliant on global partners because of the small number of patients, NIH overseas funding cuts turn patients into collateral damage By Megan Molteni STAT+ | Trump is threatening health care giants with the weight of the federal government. It's working — sometimes Trump administration health officials are skipping new laws and regulations in favor of voluntary compliance mixed with threats. Results are mixed. By Daniel Payne, Chelsea Cirruzzo, and Sarah Todd STAT+ | Health secretary RFK Jr. shuts door on U.S. investment in mRNA vaccine research Technology used during Covid pandemic long criticized by anti-vaxxers despite extensive safety data. Kennedy says he's "investing in better solutions." By Helen Branswell Aizar RALDES / AFP Lithium, a treatment for bipolar disorders, might be a key to Alzheimer's disease A study in mice finds that lithium depletion in the brain may be one of the earliest triggers of Alzheimer's and offers a potential path for treatment. By Marissa Russo STAT+ | Sarepta hired a Trump-connected firm to lobby on Duchenne treatment The biotech firm added the lobbying firm after the death of a patient who received the Duchenne muscular dystrophy treatment Elevidys. By John Wilkerson Opinion: Trump deserves the Nobel Peace Prize for Operation Warp Speed's global impact NYU's Marc Siegel says in a First Opinion essay that one way to shift the debate on mRNA vaccines is to give Trump the Nobel Prize for Operation Warp Speed. By Marc Siegel Adobe Opinion: Steve Forbes: CMS must cover FDA-approved medical devices and treatments Aligning CMS reimbursement with FDA approvals would reintroduce predictability and practicality into a system that has for too long been short on both. By Steve Forbes Opinion: Cancer care is in crisis — but I've seen what hope can do Amid devastating research cuts, oncologists need a hope that's laced with determination and innovation through action. By Fumiko Chino

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser